DataString Consulting Company Logo
DataString Consulting Company Logo
Sildenafil Citrate Market
Home»Recent Reports»Sildenafil Citrate Market

Sildenafil Citrate Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1802100, Published - March 2025

Segmented in Application (Erectile Dysfunction, Pulmonary Hypertension, High Altitude Disease, Others), Formulation (Oral, Intravenous, Sublingual), Distribution Channel, End-users, Administration Time and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Sildenafil Citrate Market Outlook

The market, for Sildenafil citrate was estimated at $1.6 billion in 2024; and it is anticipated to increase to $2.4 billion by 2030 with projections indicating a growth to around $3.2 billion by 2035. This expansion represents a compound annual growth rate (CAGR) of 6.3% over the forecast period. The notable rise in the sildenafil citrate market is mainly fueled by factors including the rising incidence of erectile dysfunction and notable progress in medical research alongside growing awareness about sexual health issues globally. The widespread acceptance and consistent demand further contribute to its growth outlook. There is competition among major pharmaceutical companies, with sildenafil citrate managing to secure its position amidst this competitive landscape successfully. Advancements in pharmaceuticals have ensured that sildenafil citrate remains highly significant and is expected to have an enduring presence, in the market going forward.


A medication called sildenafil citrate has been widely utilized for the treatment of dysfunction and pulmonary arterial hypertension due to its ability to inhibit the enzyme phosphodiesterase 5 (PDE5). This drug works by relaxing muscles and improving blood flow in targeted regions of the body to address these conditions effectively and has garnered significant attention globally as its potential, for treating other health issues is being further investigated.


Market Size Forecast & Key Insights

2019
$1.6B2024
2029
$3B2034

Absolute Growth Opportunity = $1.4B

The Sildenafil Citrate market is projected to grow from $1.6 billion in 2024 to $3.0 billion in 2034. This represents a CAGR of 6.3%, reflecting rising demand across Erectile Dysfunction Treatment, Antidepressant-Associated Sexual Dysfunction Moderation and Pulmonary Arterial Hypertension Management.

The Sildenafil Citrate market is set to add $1.4 billion between 2024 and 2034, with manufacturer targeting Pulmonary Hypertension & High Altitude Disease Application projected to gain a larger market share.

With Rising prevalence of erectile dysfunction, and Growing acceptance of sexual health medication, Sildenafil Citrate market to expand 84% between 2024 and 2034.

Opportunities in the Sildenafil Citrate Market

Strategic Collaborations for High-quality Production

The worldwide expansion of the sildenafil citrate market could benefit from partnerships between firms and suppliers of raw materials or research institutions to ensure quality control and meet increasing demand effectively. Moreover collaborating on research and development initiatives could lead to the exploration of uses, for sildenafil citrates expanding their market opportunities.

Exploring Untapped Markets and Technological Advancements in Drug Delivery Systems

In nations worldwide but notably in developing countries the need for sildenafil citrate has been comparatively low because of limited awareness, social taboos concerning erectile dysfunction and financial constraints affecting purchasing power. Nonetheless rising awareness about health matters, an increase in income levels and enhancements in healthcare services are reshaping these markets. This transformation is creating untapped potentials, for sildenafil citrate products.

In the evolving pharmaceutical sectors advancements lie an increasing focus on improving the effectiveness of drug administration techniques. Integrating sildenafil citrate into cutting edge drug delivery mechanisms such as nanoemulsions or nanocarriers could boost its availability in the body. Enhance patient adherence to treatment plans while also driving up the demand for this medical agent, on the market.

Growth Opportunities in North America and Europe

Europe Outlook

In Europe well as in other regions of sildenafil citrate market is quite profitable attracting attention because of lifestyle related health issues being common and an increase in erectile dysfunction cases among older individuals is observed with interest among marketing professionals looking for new ways to attract customers in competition, with established pharmaceutical companies promoting their products using creative tactics to meet consumers needs in this field giving pharmaceutical firms plenty of room to create and launch fresh solutions. Despite the challenges posed by regulations in the healthcare sector the increasing use of online pharmacies and telemedicine has created new opportunities, for market expansion.

North America Outlook

In North America's market scenario for sildenafil citrate is quite significant. Is mainly driven by the increasing attention towards sexual health and the rising number of older adults in the population along with the thriving healthcare setup thereabouts. The competition in this market notably involves pharmaceutical companies that offer high quality products. The key players in the industry continuously improve their strategies to boost market expansion. Although factors like regulatory guidelines growing generic competition and tough patent laws might have adverse effects, on market growth. One of the factors driving growth is the growing awareness of mens health concerns and the demand, for reliable treatment options is noteworthy too. At the forefront is the issue of dysfunction which plays an important role in the increasing use of sildenafil citrate.

North America Outlook

In North America's market scenario for sildenafil citrate is quite significant. Is mainly driven by the increasing attention towards sexual health and the rising number of older adults in the population along with the thriving healthcare setup thereabouts. The competition in this market notably involves pharmaceutical companies that offer high quality products. The key players in the industry continuously improve their strategies to boost market expansion. Although factors like regulatory guidelines growing generic competition and tough patent laws might have adverse effects, on market growth. One of the factors driving growth is the growing awareness of mens health concerns and the demand, for reliable treatment options is noteworthy too. At the forefront is the issue of dysfunction which plays an important role in the increasing use of sildenafil citrate.

Europe Outlook

In Europe well as in other regions of sildenafil citrate market is quite profitable attracting attention because of lifestyle related health issues being common and an increase in erectile dysfunction cases among older individuals is observed with interest among marketing professionals looking for new ways to attract customers in competition, with established pharmaceutical companies promoting their products using creative tactics to meet consumers needs in this field giving pharmaceutical firms plenty of room to create and launch fresh solutions. Despite the challenges posed by regulations in the healthcare sector the increasing use of online pharmacies and telemedicine has created new opportunities, for market expansion.

Growth Opportunities in North America and Europe

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : United States, Germany, United Kingdom, Japan, India are expected to grow at 4.1% to 6.0% CAGR

2

Emerging Markets : Turkey, Indonesia, South Africa are expected to grow at 7.2% to 8.7% CAGR

Market Analysis Chart

To fully grasp the ins and outs of market trends is essential in unlocking the possibilities of sildenafil citrate within the sector. The primary driving force behind the market for sildenafil citrate stems from its established effectiveness in addressing dysfunction and pulmonary arterial hypertension. The broad usage and ready access to this medication have resulted in an uptick, in demand among men aged 40 and above.

Recent Developments and Technological Advancement

December 2024

Wisk Pharmaceuticals unveiled a fast dissolving solution, for sildenafil citrate aimed at offering rapid relief to individuals struggling with erectile dysfunction.

November 2024

Vertex Health Solutions introduced a supplement that combines sildenafil citrate and L‑arginine aimed at enhancing sports performance, in specialized market segments.

October 2024

HealthMed Pharma has announced their intention to increase the production capacity of sildenafil citrate in order to meet the growing demand worldwide.

Sildenafil citrate, commonly known for its brand name Viagra, continues to dominate the erectile dysfunction treatment market. Recent advancements focus on enhancing its pharmacological profile while minimizing side effects. Notably, fast-dissolving and sublingual formulations have grabbed significant attention. The global pharmaceutical industry has seen robust growth in the erectile dysfunction drug market, with sildenafil citrate at the forefront.

Impact of Industry Transitions on the Sildenafil Citrate Market

As a core segment of the Pharmaceutical industry, the Sildenafil Citrate market develops in line with broader industry shifts. Over recent years, transitions such as Embracing Telemedicine and Advancements in Formulation have redefined priorities across the Pharmaceutical sector, influencing how the Sildenafil Citrate market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Embracing Telemedicine:

The way telemedicine operates has changed how people buy sildenafil citrate in ways. Its not only about making it more convenient and private for those dealing with issues like erectile dysfunction; its also about reaching patients in far off places. Because of this shift in approach more individuals now can get their hands on this medication through proper and legal means. This change has opened up avenues for providers to connect with customers and has led to an increase in overall usage. Overall the pharmaceutical industry has seen effects, from these changes. There have been higher sales and more opportunities to reach new markets.

2

Advancements in Formulation:

In the sildenafil citrate industry there has been progress with the introduction of news of products like chewable tablets and oral jellies which have improved how consumers perceive and use them greatly stand out different manufacturers from one another in the market competition fostering innovation and competitiveness, in the pharmaceutical sector.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Pharmaceutical industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Pharmaceutical industry cascade into the Sildenafil Citrate market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Rising Prevalence of Erectile Dysfunction, and Technological Advancements in Drug Delivery Systems

The escalating incidence of erectile dysfunction is also a significant propelling the sildenafil citrate market. Health organizations across the globe report a surge in cases of erectile dysfunction, leading to increased demand for effective solutions like sildenafil citrate. This chemical compound, being the active ingredient in leading medicines for erectile dysfunction, its demand is also projected to grow concurrently with the rising disease prevalence.
The exciting developments in drug delivery methods are also projected to boost the demand for sildenafil citrate in the market more significantly. The progress is also forecasted to enhance the effectiveness of drug absorption and enrich patients also experiences leading to adoption and favorability, towards medications based o­n sildenafil citrate.
Societys heightened acceptance and acknowledgment of sexual health issues have also removed barriers to the consumption of sildenafil citrate to treat sexual disorders. More people are also openly seeking help for problems like erectile dysfunction, leading to a more significant need for sildenafil citrate, and thus bolstering its market presence. This trend towards sexual health acceptance and the eradication of associated stigmas is also expected to continue, potentially leading to increased demand and higher market growth for sildenafil citrate.

Restraint: Stringent Regulatory Landscape

The pharmaceutical sector adheres to regulations that govern its operations and processes. Sildenafil citrate production and supply for treating dysfunction is subject to these rules which are vital, in guarantee the effectiveness and safety of the drugs. However the regulations can also present hurdles for manufacturers by impeding product innovation and market access. The significant expenses associated with compliance requirements, testing protocols and lengthy approval procedures often dissuade numerous stakeholders from engaging in this industry. The dynamics of supply and demand in the market for sildenafil citrate are greatly affected as an outcome of this situation. Furthermore government regulations not only cause delays in the introduction of new products but also restrict the availability of current ones. Lastly the use of sildenafil citrate for purposes than those approved is subject to strict regulations in numerous areas, which in turn restrains its potential, for growth.

Challenge: Potential Side Effects and Health Risks

While sildenafil citrate can be helpful, for some peoples conditions; it also comes with the risk of causing side effects.

Supply Chain Landscape

Raw Material Extraction

Nantong Jinghua

Zydus Cadila

Intermediate Manufacturing

Roche

Pfizer

Final Product Formulation
Cipla / Ranbaxy / Merck
Distribution & Sales
Fortune Health Care / Teva Pharmaceuticals
Raw Material Extraction

Nantong Jinghua

Zydus Cadila

Intermediate Manufacturing

Roche

Pfizer

Final Product Formulation

Cipla

Ranbaxy

Merck

Distribution & Sales

Fortune Health Care

Teva Pharmaceuticals

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeading Providers / ConsumersProvider Strategies
Erectile Dysfunction Treatment
Pharmaceuticals
Pfizer Inc.
Focused R&D for dosage innovation and market expansion
Pulmonary Arterial Hypertension (PAH) Treatment
Healthcare
Bayer AG
Enhanced efficacy through encapsulation technology and patient convenience optimization
Altitude Sickness Prevention
Medical
Teva Pharmaceutical Industries Ltd.
Regulated supply management to adventure medicine providers and alpine clinics
Raynaud's Phenomenon Therapy
Rheumatology
Eli Lilly and Company
Investment in advanced clinical research to establish therapeutic validity

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Sildenafil Citrate market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Sildenafil Citrate in Antidepressant-Associated Sexual Dysfunction Moderation, Pulmonary Arterial Hypertension Management and Erectile Dysfunction Treatment

Antidepressant-Associated Sexual Dysfunction Moderation

Sildenafil citrate has found another use in managing sexual issues brought on by specific antidepressants providing pharmaceutical companies producing sildenafil based treatments with an edge in the market niche, including Eli Lilly and Company which has established itself well in this field due to the need, for these specialized remedies.

Pulmonary Arterial Hypertension Management

Many people often use Sildenafil citrate to treat arterial hypertension effectively by using Revatio as a medication containing this active ingredient to relax and widen the blood vessels in the lungs arteries for better blood flow from the heart. Big pharmaceutical companies like GSK and Novartis are players in this field, in potential markets.

Erectile Dysfunction Treatment

Sildenafil citrate is widely recognized for its use in addressing dysfunction with several pharmaceutical companies utilizing this substance to create the groundbreaking blue pill known as Viagra, which has established itself as a leading choice due to its effectiveness and safety record in the market segment notably benefiting top brands, like Pfizer that have gained consumer trust and loyalty.

Sildenafil Citrate vs. Substitutes:
Performance and Positioning Analysis

Sildenafil citrate, renowned for treating erectile dysfunction, impressively outranks its alternatives in efficacy and affordability. Its market positioning underscores potential immense growth in the burgeoning male health sector. These Alternatives specially Vardenafil Hydrochloride has experienced a rapid growth as detailed in our latest report.

Sildenafil Citrate
  • Tadalafil /
  • Vardenafil Hydrochloride /
  • Avanafil
    Effective in treating erectile dysfunction, improves pulmonary arterial hypertension
    Potential side effects, not suitable for individuals with certain medical conditions
    Alternatives offer increased choice, potential for better individual compatibility
    Risk of harmful side effects, potentially decreased effectiveness compared to sildenafil citrate

Sildenafil Citrate vs. Substitutes:
Performance and Positioning Analysis

Sildenafil Citrate

  • Effective in treating erectile dysfunction, improves pulmonary arterial hypertension
  • Potential side effects, not suitable for individuals with certain medical conditions

Tadalafil / Vardenafil Hydrochloride / Avanafil

  • Alternatives offer increased choice, potential for better individual compatibility
  • Risk of harmful side effects, potentially decreased effectiveness compared to sildenafil citrate

Sildenafil citrate, renowned for treating erectile dysfunction, impressively outranks its alternatives in efficacy and affordability. Its market positioning underscores potential immense growth in the burgeoning male health sector. These Alternatives specially Vardenafil Hydrochloride has experienced a rapid growth as detailed in our latest report.

Loading...

Research Methodology

This market research methodology defines the Sildenafil Citrate market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Pharmaceutical ecosystem, we analyze Sildenafil Citrate across Adult Men, Adult Women, and Geriatric Population Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as Pfizer Inc., Eli Lilly and Company, and Teva Pharmaceuticals Industries Ltd. by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Raw Material Extraction, Intermediate Manufacturing, and Final Product Formulation. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Pharmaceutical revenues to estimate the Sildenafil Citrate segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Raw Material Extraction (Nantong Jinghua, Zydus Cadila), Intermediate Manufacturing (Roche, Pfizer), and Final Product Formulation. Our parallel substitute analysis examines Tadalafil, Vardenafil Hydrochloride, and Avanafil, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Pfizer Inc., Eli Lilly and Company, and Teva Pharmaceuticals Industries Ltd., analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Sildenafil Citrate market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Sildenafil Citrate Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 1.7 billion
Revenue Forecast in 2034USD 3.0 billion
Growth RateCAGR of 6.3% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 20241.6 billion
Growth OpportunityUSD 1.4 billion
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD billion and Industry Statistics
Market Size 20241.6 billion USD
Market Size 20272.0 billion USD
Market Size 20292.2 billion USD
Market Size 20302.4 billion USD
Market Size 20343.0 billion USD
Market Size 20353.2 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredApplication, Formulation, Distribution Channel, End-users, Administration Time
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledPfizer Inc., Eli Lilly and Company, Teva Pharmaceuticals Industries Ltd., Sandoz Inc., Aurobindo Pharma, Lupin Pharmaceuticals Inc., Dr. Reddy's Laboratories Ltd., Hetero Drugs, Torrent Pharmaceuticals Ltd., Zydus Cadila, Cipla Inc. and Sun Pharmaceuticals Industries Ltd.
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Sildenafil Citrate Market Size, Opportunities & Strategic Insights, by Application

4.1Erectile Dysfunction
4.2Pulmonary Hypertension
4.3High Altitude Disease
4.4Others
Chapter 5

Sildenafil Citrate Market Size, Opportunities & Strategic Insights, by Formulation

5.1Oral
5.2Intravenous
5.3Sublingual
Chapter 6

Sildenafil Citrate Market Size, Opportunities & Strategic Insights, by Distribution Channel

6.1Hospital Pharmacies
6.2Retail Pharmacies
6.3Online Pharmacies
Chapter 7

Sildenafil Citrate Market Size, Opportunities & Strategic Insights, by End-users

7.1Adult Men
7.2Adult Women
7.3Geriatric Population
7.4Others
Chapter 8

Sildenafil Citrate Market Size, Opportunities & Strategic Insights, by Administration Time

8.1Morning
8.2Afternoon
8.3Evening
8.4As Needed
Chapter 9

Sildenafil Citrate Market, by Region

9.1North America Sildenafil Citrate Market Size, Opportunities, Key Trends & Strategic Insights
9.1.1U.S.
9.1.2Canada
9.2Europe Sildenafil Citrate Market Size, Opportunities, Key Trends & Strategic Insights
9.2.1Germany
9.2.2France
9.2.3UK
9.2.4Italy
9.2.5The Netherlands
9.2.6Rest of EU
9.3Asia Pacific Sildenafil Citrate Market Size, Opportunities, Key Trends & Strategic Insights
9.3.1China
9.3.2Japan
9.3.3South Korea
9.3.4India
9.3.5Australia
9.3.6Thailand
9.3.7Rest of APAC
9.4Middle East & Africa Sildenafil Citrate Market Size, Opportunities, Key Trends & Strategic Insights
9.4.1Saudi Arabia
9.4.2United Arab Emirates
9.4.3South Africa
9.4.4Rest of MEA
9.5Latin America Sildenafil Citrate Market Size, Opportunities, Key Trends & Strategic Insights
9.5.1Brazil
9.5.2Mexico
9.5.3Rest of LA
9.6CIS Sildenafil Citrate Market Size, Opportunities, Key Trends & Strategic Insights
9.6.1Russia
9.6.2Rest of CIS
Chapter 10

Competitive Landscape

10.1Competitive Dashboard & Market Share Analysis
10.2Company Profiles (Overview, Financials, Developments, SWOT)
10.2.1Pfizer Inc.
10.2.2Eli Lilly and Company
10.2.3Teva Pharmaceuticals Industries Ltd.
10.2.4Sandoz Inc.
10.2.5Aurobindo Pharma
10.2.6Lupin Pharmaceuticals Inc.
10.2.7Dr. Reddy's Laboratories Ltd.
10.2.8Hetero Drugs
10.2.9Torrent Pharmaceuticals Ltd.
10.2.10Zydus Cadila
10.2.11Cipla Inc.
10.2.12Sun Pharmaceuticals Industries Ltd.